CIM - NYSE

Chimera Investment Corporation

CIM·NYSE

$13.14

-3.0%

Real EstateREIT - Mortgage

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency and non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of residential, commercial mortgage loans, and other real estate related securities. It has elected to be taxed as a REIT. In addition, the company invests in investment, non-investment grade, and non-rated classes. The company was incorporated in 2007 and is based in New York, New York.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.10B

EPS2.8000

P/E Ratio4.69

Earnings Date07/30/2026

15.81B

Assets

21%

3Y+18.0%

5Y-10.0%

10Y-5.0%

13.24B

Total Liabilities

25%

3Y+23.0%

5Y-4.0%

10Y-2.0%

2.57B

Total Equity

3Y-4.0%

5Y-32.0%

10Y-84.0%

Chimera Investment Corporation Funding & Solvency Profile

CIM · NYSE

Current Assets

Cash & Cash Equivalents278.58M

Net Receivables115.98M

Inventory0.00

Other Current Assets0.00

Total Current Assets395 M

Non-Current Assets

Property, Plant & Equipment0.00

Goodwill & Intangible Assets0.00

Long-Term Investments4.28B

Other Non-Current Assets11.13B

Total Non-Current Assets15 B

Total Assets

15.81B

Financial Health Analysis

Current Ratio

0.07x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

5.14x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

-5636615000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

2% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

Chimera Investment Corporation Balance Sheet

CIM • NYSE

Chimera Investment Corporation Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	278.6M	84M	221.7M	264.6M	385.7M	269.1M	109.9M	47.5M	63.6M	177.7M	114.1M	164.6M	77.6M	621.2M	206.3M	7.2M	24.3M	27.5M	0.0
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	855.5M	1.1B
Cash & Short-Term Investments	278.6M	84.1M	221.7M	264.6M	385.7M	269.1M	109.9M	47.5M	63.6M	177.7M	114.1M	164.6M	77.6M	621.2M	206.3M	7.2M	24.3M	882.9M	1.1B
Net Receivables	116M	11.2B	11.4B	11.4B	12.3B	13.1B	562.6M	123.4M	100.8M	79.7M	66.2M	1.6B	286.5M	39.3M	49.3M	49.1M	33.1M	10M	6M
Accounts Receivables	116M	11.2B	11.4B	11.4B	12.3B	13.1B	116.4M	123.4M	100.8M	79.7M	66.2M	71.1M	33M	39.3M	49.3M	0.0	33.1M	10M	0.0
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	446.2M	0.0	0.0	0.0	0.0	1.6B	253.5M	0.0	0.0	49.1M	0.0	0.0	6M
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-37.5M	-48.9M	-9.7M	-15.5M	-3.6M	-8.1M	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Assets	0.0	85.9M	88.5M	140.1M	88.6M	81.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Current Assets	394.6M	11.4B	11.7B	11.8B	12.7B	13.5B	672.5M	47.5M	63.6M	177.7M	114.1M	164.6M	77.6M	621.2M	255.6M	56.3M	57.4M	892.9M	1.1B
NON-CURRENT ASSETS
Long-Term Investments	4.3B	1.6B	1.2B	1.6B	2.6B	4B	12B	14.7B	7.2B	7.5B	10.2B	11.8B	2.8B	2.5B	7.2B	7.3B	4.1B	855.5M	0.0
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	27.1B	27.7B	21.2B	16.7B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	11.1B	102.4M	30.4M	34.1M	39.2M	78.8M	-27.1B	-29.5B	-7.4B	-7.8B	5B	7.1B	4B	4.6B	258M	354.7M	472M	-270.9M	0.0
Total Non-Current Assets	15.4B	1.7B	1.2B	1.6B	2.7B	4.1B	12B	12.9B	21B	16.4B	15.2B	18.9B	6.8B	7.1B	7.5B	7.7B	4.6B	584.6M	0.0
Other Assets	0.0	0.0	0.0	0.0	0.0	0.0	14.5B	14.8B	114.8M	79.7M	66.2M	71.1M	18.1M	18.7M	0.0	0.0	0.0	0.0	1.6B
Total Assets	15.8B	13.1B	12.9B	13.4B	15.4B	17.5B	27.1B	27.7B	21.2B	16.7B	15.3B	19.2B	6.9B	7.7B	7.7B	7.7B	4.6B	1.5B	1.6B
LIABILITIES
CURRENT LIABILITIES
Total Payables	0.0	499.8M	168.2M	25.9M	489M	111.9M	1.4B	1.3B	724.7M	666.2M	688.2M	2B	310.2M	110.9M	137.3M	315M	122.8M	9.7M	0.0
Accounts Payable	0.0	499.8M	168.2M	25.9M	489M	111.9M	63.6M	110.4M	61.9M	48.7M	37.4M	31.9M	6.7M	10.8M	11.4M	393K	472K	387K	0.0
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	-63.6M	-110.4M	-61.9M	-48.7M	-37.4M	-31.9M	-6.7M	100.1M	125.9M	-393K	122.3M	9.3M	0.0
Accrued Expenses	0.0	41.5M	38.3M	30.7M	20.4M	41M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4M	11.6M	3.2M	2.5M	0.0
Short Term Debt	6B	3.8B	2.7B	4B	4.9B	5.4B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	-15B	-7B	-9.6B	-7.3B	-7.4B	-9B	-2.1B	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	0.0	34.3M	54.6M	64.5M	86.2M	77.2M	-1.4B	15.2B	8.8B	6.8B	7.3B	9.1B	2.1B	2.2B	-9.7M	0.0	0.0	0.0	0.0
Total Current Liabilities	6B	4.4B	2.9B	4.1B	5.5B	5.7B	69.8M	15.4B	8B	6.3B	8.1B	10.5B	2B	1.7B	139M	314.2M	126M	12.2M	0.0
NON-CURRENT LIABILITIES
Long Term Debt	7B	6.2B	7.4B	6.6B	6.2B	8.1B	7.6B	7.5B	16.8B	12.9B	11.7B	5.1B	3.3B	4B	2.7B	4.1B	2.4B	1.1B	0.0
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	23.2B	24B	17.6B	13.6B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	-1.4B	-24B	-17.6B	-13.6B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	165.3M	0.0	0.0	0.0	0.0	0.0	-7.6B	0.0	-8.8B	-6.8B	-7.3B	-5.1B	-3.3B	-4B	1.9B	10M	0.0	0.0	0.0
Total Non-Current Liabilities	7.2B	6.2B	7.4B	6.6B	6.2B	8.1B	21.7B	8.6B	9.6B	7.3B	4.2B	5.1B	1.6B	2.5B	4.6B	4.1B	2.4B	1.1B	0.0
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	1.4B	0.0	0.0	0.0	0.0	315K	-429K	10K	0.0	0.0	0.0	0.0	1B
Capital Lease Obligations	0.0	0.0	0.0	0.0	0.0	0.0	930.4M	730.3M	470.2M	145.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	13.2B	10.6B	10.4B	10.7B	11.7B	13.7B	23.2B	24B	17.6B	13.6B	12.4B	15.5B	3.6B	4.2B	4.7B	4.4B	2.5B	1.1B	1B
SHAREHOLDERS' EQUITY
Preferred Stock	372K	372K	372K	372K	372K	372K	372K	292K	188K	58K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	834K	809K	804K	2.3M	2.4M	2.3M	1.9M	1.9M	1.9M	1.9M	1.9M	10.3M	10.3M	10.3M	10.3M	10.3M	6.7M	1.8M	0.0
Additional Paid-In Capital	4.4B	4.4B	4.4B	4.3B	4.4B	4.5B	4.3B	4.1B	3.8B	3.5B	3.4B	3.6B	3.6B	3.6B	3.6B	3.6B	2.3B	832M	532.6M
Retained Earnings	-2B	-2B	-2B	-1.9B	-1B	-1.3B	-1B	-997.3M	-990.7M	-1.1B	-1.2B	-1.1B	-1.3B	-1.1B	-999.8M	-203.8M	-71M	-152.6M	-3.8M
Accumulated Other Comprehensive Income/Loss	146.3M	159.4M	185.7M	229.3M	405.1M	558.1M	708.3M	626.8M	796.9M	718.1M	773.8M	1B	990.8M	989.9M	433.5M	-90.5M	-99.8M	-266.7M	10M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	770.6M	0.0	0.0	0.0
Total Stockholders' Equity	2.6B	2.5B	2.6B	2.7B	3.7B	3.8B	4B	3.7B	3.6B	3.1B	2.9B	3.6B	3.3B	3.5B	3B	3.3B	2.1B	414.5M	538.9M
Total Equity	2.6B	2.5B	2.6B	2.7B	3.7B	3.8B	25.6B	26.3B	20.4B	15.8B	2.9B	3.6B	3.3B	3.5B	3B	3.3B	2.1B	414.5M	538.9M
Minority Interest	0.0	0.0	0.0	0.0	0.0	0.0	21.6B	22.6B	16.8B	12.7B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	15.8B	13.1B	12.9B	13.4B	15.4B	17.5B	27.1B	27.7B	21.2B	16.7B	15.3B	19.2B	6.9B	7.7B	7.7B	7.7B	4.6B	1.5B	1.6B
Total Investments	4.3B	1.6B	1.2B	1.6B	2.6B	4B	12B	14.7B	7.2B	7.5B	10.2B	11.8B	2.8B	2.5B	7.2B	7.3B	4.1B	1.7B	1.1B
Total Debt	13.1B	10B	10.1B	10.6B	11.1B	13.5B	21.7B	22.6B	16.8B	12.9B	11.7B	5.1B	1.6B	2.5B	2.7B	4.1B	2.4B	1.1B	0.0
Net Debt	12.8B	9.9B	9.9B	10.3B	10.7B	13.2B	21.6B	22.6B	16.8B	12.7B	11.6B	4.9B	1.5B	1.9B	2.5B	4.1B	2.3B	1B	0.0
Shares Outstanding	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395	81,075,395

SEC Filings

CIM - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2025 N/A	December 18, 2025	December 18, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 06, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 06, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 05, 2025	November 05, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 03, 2025	October 01, 2025	2025	View Filing
8-K 8-K 2025 N/A	September 18, 2025	September 18, 2025	2025	View Filing
8-K 8-K 2025 N/A	September 16, 2025	September 16, 2025	2025	View Filing
8-K 8-K 2025 N/A	September 10, 2025	September 09, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 06, 2025	June 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 06, 2025	August 06, 2025	2025	View Filing

Showing 1 to 10 of 375 filings

Related Guides

Blog Categories

Continue your CIM research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.